Healthy Skepticism Library item: 11933
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Hall RF.
The risk of risk reduction: can postmarket surveillance pose more risk than benefit?
Food Drug Law J 2007; 62:(3):473-92
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915389
Abstract:
No abstract available.
Keywords:
MeSH Terms:
Antiemetics/adverse effects
Data Collection
Defibrillators, Implantable/adverse effects
Device Approval*
Disclosure
Doxylamine/adverse effects
Drug Approval/methods
Drug Industry/legislation & jurisprudence
Equipment Safety
Female
Humans
Legislation, Drug/trends
Male
Pregnancy
Product Surveillance, Postmarketing*
Risk Management*
Serotonin Uptake Inhibitors/adverse effects
United States
United States Food and Drug Administration
Substances:
Antiemetics
Serotonin Uptake Inhibitors
Doxylamine
